Recent Research Analysts’ Ratings Updates for Prestige Consumer Healthcare (PBH)

Posted by on May 21st, 2026

A number of research firms have changed their ratings and price targets for Prestige Consumer Healthcare (NYSE: PBH):

  • 5/18/2026 – Prestige Consumer Healthcare was downgraded by Zacks Research from “hold” to “strong sell”.
  • 5/15/2026 – Prestige Consumer Healthcare had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a “buy” rating on the stock.
  • 5/14/2026 – Prestige Consumer Healthcare was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
  • 5/14/2026 – Prestige Consumer Healthcare was downgraded by Oppenheimer Holdings, Inc. from “outperform” to “market perform”.
  • 5/7/2026 – Prestige Consumer Healthcare had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an “outperform” rating on the stock.
  • 4/21/2026 – Prestige Consumer Healthcare had its “hold (c)” rating reaffirmed by Weiss Ratings.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, VP Jeffrey Zerillo sold 1,207 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $54.99, for a total transaction of $66,372.93. Following the completion of the sale, the vice president directly owned 42,820 shares in the company, valued at approximately $2,354,671.80. The trade was a 2.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.40% of the company’s stock.

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).

Read More

Receive News & Ratings for Prestige Consumer Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.